ONCAlert | Upfront Therapy for mRCC
News
Treatment Options Evolve in Nonresectable, Non-Transplantable Liver-Only HCC Paradigm
9:51 PM, Mon November 18, 2019
Expert Discusses the Safety and Efficacy of Mirvetuximab Soravtansine in Ovarian Cancer Following FORWARD I Findings
1:44 PM, Mon November 18, 2019
Gefitinib/Chemotherapy Combo Decreases Risk of Disease Progression in EGFR+ NSCLC
5:45 PM, Fri November 15, 2019
Emerging Data Concerning Modifiable Host Factors and Immune Responses Fuel Discussion
3:16 PM, Fri November 15, 2019
FDA Approves Zanubrutinib for Previously Treated MCL
10:58 PM, Thu November 14, 2019
Study Continues to Show Superiority with Nivolumab Vs. Ipilimumab For Resected Stage III/IV Melanoma
8:23 PM, Thu November 14, 2019
FDA Grants Priority Review to Selumetinib for Neurofibromatosis Type 1 in Pediatric Patients
4:12 PM, Thu November 14, 2019
Clarifying Mechanisms of Resistance May Enhance Treatment Strategies
3:00 PM, Thu November 14, 2019
